Nvelop Therapeutics Overview
- Year Founded
-
2022
- Status
-
Acquired/Merged
- Employees
-
74
- Latest Deal Type
-
M&A
Nvelop Therapeutics General Information
Description
Developer of genetic medicines intended to help patients suffering from severe genetic diseases. The company utilizes novel gene editing delivery technologies to develop genetic medicines to target cells within the body to help treat patients with previously undruggable diseases, enabling medical stores to deliver a variety of therapeutic payloads, focusing initially on gene editing in therapeutically relevant cells and tissues.
Contact Information
Website
www.nveloptx.comCorporate Office
- 100 Technology Square
- Fifth Floor
- Cambridge, MA 02139
- United States
Corporate Office
- 100 Technology Square
- Fifth Floor
- Cambridge, MA 02139
- United States
Nvelop Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 11-Dec-2024 | Completed | Out of Business | |||
| 2. Early Stage VC | 16-Apr-2024 | Completed | Generating Revenue | |||
| 1. Seed Round | 21-Jul-2022 | $100M | $100M | Completed | Startup |
Nvelop Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Nvelop Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Nvelop Therapeutics Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 5AM Ventures | Venture Capital | Minority | ||
| ARCH Venture Partners | Venture Capital | Minority | ||
| Atlas Venture | Venture Capital | Minority | ||
| F-Prime Capital | Venture Capital | Minority | ||
| GV | Corporate Venture Capital | Minority |
Nvelop Therapeutics FAQs
-
When was Nvelop Therapeutics founded?
Nvelop Therapeutics was founded in 2022.
-
Where is Nvelop Therapeutics headquartered?
Nvelop Therapeutics is headquartered in Cambridge, MA.
-
What is the size of Nvelop Therapeutics?
Nvelop Therapeutics has 74 total employees.
-
What industry is Nvelop Therapeutics in?
Nvelop Therapeutics’s primary industry is Drug Discovery.
-
Is Nvelop Therapeutics a private or public company?
Nvelop Therapeutics is a Private company.
-
What is Nvelop Therapeutics’s current revenue?
The current revenue for Nvelop Therapeutics is .
-
How much funding has Nvelop Therapeutics raised over time?
Nvelop Therapeutics has raised $147M.
-
Who are Nvelop Therapeutics’s investors?
5AM Ventures, ARCH Venture Partners, Atlas Venture, F-Prime Capital, and GV are 5 of 6 investors who have invested in Nvelop Therapeutics.
-
When was Nvelop Therapeutics acquired?
Nvelop Therapeutics was acquired on 11-Dec-2024.
-
Who acquired Nvelop Therapeutics?
Nvelop Therapeutics was acquired by nChroma Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
